Knowledge Graphs In Drug Discovery вђ Wisecube Ai вђ Research How harmonized data can unlock opportunities in artificial intelligence (ai) and machine learning for drug discovery & development — a deep dive into the e therapeutics approach: a. how knowledge graphs accelerate drug discovery by harmonizing disparate, siloed data across biopharma companies b. How knowledge graphs accelerate drug discovery in biotechs. in this webinar, you'll hear from paul vauterin, the former cio of aelin therapeutics, a biotech company leveraging targeted protein aggregation to develop an entirely new class of therapeutics aiming at hard to treat targets in cancer and infectious diseases.
Ontoforce Webinar How Knowledge Graphs Accelerate Drug Discovery Paul is responsible for bioinformatics and data science activities, which are crucial elements of the company’s drug discovery and development platform. and also, james longden, head of discovery biology at e therapeutics, a biotech company that integrates computational power and biology to discover life transforming rnai medicines. james is. 1 people interested. check out who is attending exhibiting speaking schedule & agenda reviews timing entry ticket fees. 2022 edition of how biotechs accelerate drug discovery with knowledge graphs will be held at online starting on 27th september. it is a 1 day event organised by ontoforce and will conclude on 27 sep 2022. In this free webinar, learn how a data science and computational strategy can deliver value in drug discovery and development and pioneer an end user approach . how knowledge graphs accelerate drug discovery in biotechs, upcoming webinar hosted by xtalks. A few weeks ago, we at ontoforce hosted our latest webinar focusing on knowledge graphs and drug discovery in biotechs. on the topic, we had the pleasure of hearing from paul vauterin, cio of.
Comments are closed.